Active Immunization of Children with Leukemia and Other Malignancies

Bibliography

• Feldman S., Gigliotti F., Shenep J. L., Robertson P. K., Lott L. Risk of Haemophilus influenza type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. J. Infect. Dis. 1990; 161: 926–931
   PubMed Web of Science ®Google Scholar
• Saarinen U. M. Severe infections in childhood leukemia: a follow-up study of 100 consecutive ALL patients. Acta Paediatr. Scand. 1984; 73: 515–522
   PubMed Web of Science ®Google Scholar
• Siber G. R. Bacteremias due to Haemophilus influenza and Streptococcus pneumonia: their occurrence and course in children with cancer. Am. J. Dis. Child 1988; 142: 419–420
   Google Scholar
• King B. R., Bell L. M., Marshall G. S. Haemophilus influenza type b bacteremia in older children. Pediatric. Emerg. Care 1991; 7: 331–333
   PubMedGoogle Scholar
• Weisman S. J., Cates K. L., Allegretta G. J., Quinn J. J., Altman A. J. Antibody response to immunization with Haemophilus influenza type b polysaccharide vaccine in children with cancer. J. Pediatr. 1987; 111: 727–729
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Update: prevention of Haemophilus influenza type b infections in the United States. M.M.W.R. 1988; 37: 13–19
   PubMedGoogle Scholar
• Hughes W. T., Kuhn S., Chaudhary S., Feldman S., Verzosa M., Aur R. J. A., Pratt C., George S. L. Successful chemoprophylaxis for pneumocystis carinii pneumonitis. N. Engl. J. Med. 1979; 300: 203–204
   Google Scholar
• Shapiro E. D. New vaccines against Haemophilus influenza type b. Pediatr. Clin. N.A. 1990; 37: 567–583
   PubMed Web of Science ®Google Scholar
• Gigliotti F., Feldman S., Shenep J., Lott L. Response of children with acute lymphoblastic leukemia (ALL) to H. influenza type B (Hib) conjugate vaccine. Ped. Res. 1988; 23: 369A
   Google Scholar
• Ridgway D., Wolff L. J., Deforest A. Immunization response varies with intensity of acute lymphoblastic leukemia therapy. Am. J. Dis. Child. 1991; 145: 887–891
   PubMedGoogle Scholar
• Lange B., Jakacki R., Nasab A. H., Luery N., McVerry P. H. Immunization of leukemic children with Haemophilus conjugate vaccine. J. Ped. Infect. Dis. 1989; 8: 883–884
   PubMed Web of Science ®Google Scholar
• Hetherington M. L., Buchana G. R. Elevated serum transaminase values during therapy for acute lymphoblastic leukemia correlate with prior blood transfusions. Cancer 1988; 62: 1614–1618
   PubMed Web of Science ®Google Scholar
• Locasciulli A., Mieli-Vergani G., Uderzo C., Jean G., Cattaneo M., Vergani D., Portmann B., Masera G. Chronic liver disease in children with leukemia in long-term remission. Cancer 1983; 52: 1080–1087
   PubMed Web of Science ®Google Scholar
• Locasciulli A., Alberti A., Rossetti F., Santarmaria M., Santoro N., Madon E., Miniero R., Lo Curto M., Tamaro P., Paolucci P., Casale F., Nespoli L., Tucci F., Masera G. Acute and chronic hepatitis in childhood leukemia: a multicentric study from the Italian Pediatric Cooperative Group for Therapy of Acute Leukemia (AIL-AIEOP). Med. Pediatr. Oncolog. 1985; 13: 203–206
   PubMedGoogle Scholar
• Locasciulli A., Gornati G., Tagger A., Ribero M. L., Cavalletto D., Cavalletto L., Masera G., Shulman H. M., Portmann B., Alberti A. Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. Blood 1991; 78: 1619–1622
   PubMed Web of Science ®Google Scholar
• Ratner L. Delta hepatitis outbreak in a group of patients with leukemia. Ann. Intern. Med. 1986; 105: 972
   PubMed Web of Science ®Google Scholar
• Lambert F., Willems W. R., Bertram U., Berthold F. No adverse prognostic influence of hepatitis B virus infection in acute lymphoblastic leukemia. Blut 1987; 55: 115–120
   PubMedGoogle Scholar
• Ratner L., Peylan-Ramu N., Wesley R., Poplack D. G. Adverse prognostic influence of hepatitis B virus infection in acute lymphoblastic leukemia. Cancer 1986; 58: 1096–1100
   PubMed Web of Science ®Google Scholar
• Tabor E., Gerrety R. J., Mott M., Wilbur J. Prevalence of hepatitis B in high-risk setting: a serologic study of patients and staff in a pediatric oncology unit. Pediatrics 1978; 61: 711–715
   PubMed Web of Science ®Google Scholar
• Entacher U., Jurgenssen O., Thus-Hohenstein L., Simbruner G., Khoss A., Wank H., Neuwirth G., Gadner H., Frisch-Niggemeyer W. Hepatitis B vaccination and immune response in children with malignant diseases. Eur. J. Pediatr. 1985; 144: 160–163
   PubMed Web of Science ®Google Scholar
• Boguslawska-Jaworska J., Gorczynska E., Seyfried H., Gladysz A., Zalewska M. Passive and active anti-hepatitis B immunization of children with hematologic malignancies. Haematolog. Blood Transfus. 1987; 30: 530–534
   PubMedGoogle Scholar
• Locasciulli A., Santamaria M., Masera G., Schiavon E., Alberti A., Realdi G. Hepatitis B virus markers in children with acute leukemia: the effect of chemotherapy. J. Med. Virol. 1985; 15: 29–33
   PubMed Web of Science ®Google Scholar
• Pontisso P., Locasciulli A., Schiavon E., Cattoretti G., Schiro R., Stenico D., Alberti A. Detection of hepatitis B virus DNA sequences in bone marrow of children with leukemia. Cancer 1987; 59: 292–296
   PubMed Web of Science ®Google Scholar
• Rosetti F., Zancan L., Perilongo G., Zanesco L. Hepatocellular carcinoma following chronic delta virus hepatitis in a patient cured of leukemia. Med. Pediatr. Oncolog. 1991; 19: 137–138
   PubMedGoogle Scholar
• Cheah P. L., Looi L. M., Lin H. P., Yap S. F. A case of childhood hepatitis B virus infection related primary hepatocellular carcinoma with short malignant transformation. Pathology 1991; 23: 66–68
   PubMed Web of Science ®Google Scholar
• Locasciulli A., Pontisso P., Schiavon E., Sala E., Chemello L., Masera G., Alberti A. Monoclonal radioimmunoassay for hepatitis B surface antigen in sera of children with acute leukemia. J. Med. Virol. 1986; 20: 101–104
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Hepatitis B virus. A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunizations Practices Advisory Committee (ACIP). MMWR 1991; 40(RR-13)1–19
   PubMedGoogle Scholar
• Committee on Infectious Diseases, American Academy of Pediatrics. Immunization in special clinical circumstances. Report of the Committee on Infectious Diseases, 22 ed. American Academy of Pediatrics, Elk Grove Village, IL 1991; 46–66
   Google Scholar
• Kempe A., Hall C. B., MacDonald N. E., Foye H. R., Woodin K. A., Cohen H. J., Lewis E. D., Gullace M., Gala C. L., Dulberc C. S., Katsanis E. Influenza in children with cancer. J. Pediatr. 1989; 115: 33–39
   PubMed Web of Science ®Google Scholar
• Feldman S., Webster R. G., Sugg M. Influenza in children and young adults with cancer; 20 cases. Cancer 1977; 39: 350–353
   PubMed Web of Science ®Google Scholar
• Steinherz P. G., Brown A. E., Gross P. A., Braun D., Ghavimi F., Wollner N., Rosen G., Armstrong D., Miller D. R. Influenza immunization of children with neoplastic diseases. Cancer 1980; 45: 750–756
   PubMed Web of Science ®Google Scholar
• Allison J. E., Glezen W. P., Taber L. H., Paredes A., Webster R. G. Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children. J. Infect. Dis. 1977; 136: S672–675
   PubMed Web of Science ®Google Scholar
• Gross P. A., Lee H., Wolff J. A., Hall C. B., Minnefore A. B., Lazicki M. E. Influenza immunization in immunocompromised children. J. Pediatr. 1978; 92: 30–35
   PubMed Web of Science ®Google Scholar
• Smithson W. A., Siem R. A., Ritts R. E., Gilchrist G. S., Burgert O., Ilstrup D. M., Smith T. F. Response to influenza virus vaccine in children receiving chemotherapy for malignancy. J. Pediatr. 1978; 93: 632–634
   PubMed Web of Science ®Google Scholar
• Lange B., Shapiro S. A., Waldman M. T. G., Proctor E., Arbeter A. Antibody responses to influenza immunization of children with acute lymphoblastic leukemia. J. Infect. Dis. 1979; 140: 402–406
   PubMed Web of Science ®Google Scholar
• Sumaya C. V., Williams T. E., Brunell P. A. Bivalent influenza vaccine in children with cancer. J. Infect. Dis. 1977; 136: S656–660
   PubMed Web of Science ®Google Scholar
• Heilman C., La Montagne J. R. Influenza; status and prospects for its prevention, therapy, control. Pediatr. Clin. NA. 1990; 37: 669–688
   PubMed Web of Science ®Google Scholar
• Ruben F. L. Prevention and control of influenza; role of vaccine. Amer. J. Med. 1987; 82(Supp 6A)31–34
   PubMed Web of Science ®Google Scholar
• Brunel L. P. A. Immunologic response of immunosup-pressed children to influenza vaccine. MMWR 1977; 26: 54
   Google Scholar
• Gross P. A. Reactogenicity and immunogenicity of bivalent influenza vaccine in one- and two-dose trials in children. A summary. J. Infect. Dis. 1977; 136: S616–625
   PubMedGoogle Scholar
• Borella L., Webster R. G. The immunosuppressive effects on long-term combination chemotherapy in children with acute leukemia in remission. Cancer Res. 1971; 31: 420–426
   PubMed Web of Science ®Google Scholar
• Brown A. E., Steinherz G., Miller D. R., Armstrong D., Kellick M. G. Immunization against influenza in children with cancer: results of a three-dose trial. J. Infect. Dis. 1982; 145: 126
   PubMed Web of Science ®Google Scholar
• Sumaya C. V., Williams T. E. Persistence of antibody after the administration of influenza vaccine to children with cancer. Pediatr. 1982; 69: 226–229
   PubMed Web of Science ®Google Scholar
• Hall C. B. Influenza: a shot or not?. Pediatr. 1987; 79: 564–566, Measles
   PubMed Web of Science ®Google Scholar
• Breitfield V., Hashida Y., Sherman F. E., Odagiri K., Yunis E. J. Fatal measles infection in children with leukemia. Labor at. Investig. 1973; 28: 279–291
   PubMed Web of Science ®Google Scholar
• Kernahan J., McQuillin J., Craft A. W. Measles in children who have malignant disease. Brit. Med. J. 1987; 295: 15–18
   PubMed Web of Science ®Google Scholar
• Gray M. M., Hann I. M., Glass S., Eden O. B., Jones P. M., Stevens R. F. Mortality and morbidity caused by measles in children with malignant disease attending four major treatment centers: a retrospective review. Brit. Med. J. 1987; 295: 19–22
   PubMed Web of Science ®Google Scholar
• Feldman S., Gigliotti F., Bockhold C., Naegele R. Measles and rubella antibody status in previously vaccinated children with cancer. Med. Pediatr. Oncolog. 1988; 16: 308–311
   PubMedGoogle Scholar
• Mitus A., Holloway A., Evans A. E., Enders J. F. Attenuated measles vaccine in children with acute leukemia. Am. J. Dis. Child. 1962; 103: 243–248
   Google Scholar
• Torigue S., Hirai S., Oitan K. Application of live attenuated measles and mumps vaccine in children with acute leukemia. Biken. J. 1981; 24: 147–151
   PubMedGoogle Scholar
• Committee on Infectious Diseases, American Academy of Pediatrics. Active immunization, vaccine safety and contraindications. Report of the Committee on Infectious Diseases, 22 ed. American Academy of Pediatrics, Elk Grove Village, IL 1991; 22–32
   Google Scholar
• Isaacs D., Menser M. Modern vaccines. Measles, mumps, rubella, varicella. Lancet 1990; 335: 1384–1387
   PubMed Web of Science ®Google Scholar
• Gillum J. E., Garrison M. W., Crossley K. B., Rotschafer J. C. Current immunization practices. 1 Polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, and influenza. Postgrad. Med. 1989; 85: 183–198
   PubMed Web of Science ®Google Scholar
• Srugo I., Brunel L. P. A. Measles vaccine. Pediatr. Ann. 1990; 19: 708–711
   PubMed Web of Science ®Google Scholar
• Legler J. D. Contraindications to live-viral immunization. J. Fam. Prac. 1989; 28: 333–334
   PubMed Web of Science ®Google Scholar
• Banatrala J. E. Measles must go and with it rubella. Brit. Med. J. 1987; 295: 2–3
   PubMed Web of Science ®Google Scholar
• Miller C. Live measles vaccine: a 21 year follow up. Brit. Med. J. 1987; 295: 22–24
   PubMed Web of Science ®Google Scholar
• Folland D., Armstrong D., Seides S., Blevins A. Pneumococcal bacteremia in patients with neoplastic disease. Cancer 1974; 33: 845–849
   PubMed Web of Science ®Google Scholar
• Chou M. Y., Brown A. E., Blevins A., Armstrong D. Severe pneumococcal infection in patients with neoplastic disease. Cancer 1983; 51: 1546–1550
   PubMed Web of Science ®Google Scholar
• Lambert H. P. Vaccination against pneumococcal disease. Arch. Dis. Child 1980; 55: 915–916
   PubMed Web of Science ®Google Scholar
• Austrian R. The assessment of pneumococcal vaccine. JV. Eng. J. Med. 1980; 303: 578–580
   PubMed Web of Science ®Google Scholar
• Committee on Infectious Diseases, American Academy of Pediatrics. Pneumococcal infections. Report of the Committee on Infectious Diseases, 22 ed. American Academy of Pediatrics, Elk Grove Village, IL 1991; 373–378
   Google Scholar
• Feldman S., Malone W., Wilbur R., Schiffman G. Pneumococcal vaccination in children with acute lymphoblastic leukemia. Med. Pediatr. Oncolog. 1985; 13: 69–72
   PubMedGoogle Scholar
• Lindblad R., Kaijser B., Magnusson B., Rodjer S., Westin J. Pneumococcal vaccination in splenecto-mized patients with hematological disorders. Acta. Med. Scand. 1988; 224: 467–471
   PubMed Web of Science ®Google Scholar
• Kafidi K. T., Rotschafer J. C. Bacterial vaccines for splenectomized patients. Drug Intell. Clin. Pharmacol. 1988; 22: 192–197
   PubMedGoogle Scholar
• Minor D. R., Schiffman G., McIntosh L. S. Response of patients with Hodgkin's disease to pneumococcal vaccine. Ann. Int. Med. 1979; 90: 887–892
   PubMed Web of Science ®Google Scholar
• Amman A. J., Addiego J., Wara D. W., Lubin B., Smith W. B., Mentzer W. C. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N. Eng. J. Med. 1977; 297: 897–900
   PubMed Web of Science ®Google Scholar
• Amman A. J., Schiffman G., Addiego J. E., Wara W. M., Wara D. W. Immunization of immunosuppressed patients with pneumococcal polysaccharaide vaccine. Rev. Infect. Dis. 1981; 3: S160–S167
   Google Scholar
• Siber G. R., Weitzman S. A., Aisenberc A. C., Weinstein H. J., Schiffman G. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N. Eng. J. Med. 1978; 299: 442–448
   PubMed Web of Science ®Google Scholar
• Appelbaum P. C., Shaikh B. S., Widome M. D., Gordon R. A., Austrian R. Fatal pneumococcal bacteremia in a vaccinated splenectomized child. N. Engl. J. Med. 1979; 300: 203–204
   PubMed Web of Science ®Google Scholar
• Forrester H. L., Jahnigen D. W., LaForce F. M. Inefficacy of pneumococcal vaccine in a high-risk population. Amer. J. Med. 1987; 83: 425–430, See also Hughes et al. (reference 7) and Siber et al. (reference 3)
   PubMed Web of Science ®Google Scholar
• Sutter R. W., Onorato I. M., Patriarca P. A. Current poliomyelitis immunization policy in the United States. Pediatr. Ann. 1990; 19: 702–706
   PubMed Web of Science ®Google Scholar
• Kimpen J. L. L., Ogra P. L. Poliovirus vaccines; a continuing challenge. Pediatr. Clin. NA. 1990; 37: 627–650
   PubMed Web of Science ®Google Scholar
• Dupuy J. M., Kourilsky F. M., Fradeliaai D., Feingold N., Jacquillat C., Bernard J., Dausset J. Depression of immunologic reactivity of patients with acute leukemia. Cancer 1971; 27: 323–331
   PubMed Web of Science ®Google Scholar
• Ogra P. L., Sinks L. F., Karzon D. R. Poliovirus antibody response in patients with acute leukemia. J. Pediatr. 1971; 79: 444–449
   PubMed Web of Science ®Google Scholar
• Bosu S. K., Ciudad H., Sinks L. F., Ogra P. I. Antibody response to poliovirus immunization in childhood leukemia. Med. Pediatr. Oncolog. 1975; 1: 217–225
   PubMedGoogle Scholar
• Van der Does-van den Berc A., Hermans J., Nage L. J., van Steenis G. Immunity to diphtheria, pertussis, tetanus, and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy. Pediatr. 1981; 67: 222–229
   PubMed Web of Science ®Google Scholar
• Graham-Pole J., Willoughby M. L. N., Aitken S., Ferguson A. Immune status of children with and without severe infection during remission of malignant disease. Brit. Med. J. 1975; 2: 467–470
   PubMed Web of Science ®Google Scholar
• Mellander L., Bjorkander J., Carlsson B., Hanson L. A. Secretory antibodies in IgA-deficient and immunosup-pressed individuals. J. Clin. Immunol. 1986; 6: 284–291
   PubMed Web of Science ®Google Scholar
• Frenkel L. D. Routine immunizations for American children in the 1990's. Pediatr. Clin. NA. 1990; 37: 531–548
   PubMed Web of Science ®Google Scholar
• Kunc F. H., Orgel H. A., Wallace W. W., Hamberger R. N. Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease. Pediatr. 1984; 74: 86–89
   PubMed Web of Science ®Google Scholar
• Nyerges G., Zimonyi I., Nyerges G., Meszner A., Marosi A. Efficiency of tetanus toxoid booster in leukemic children. Acta. Paediatr. Acad. Scientiarum. Hung. 1981; 22: 237–241
   PubMedGoogle Scholar
• Hitzic W. H., Pluss H. J., Joler P., Pilgrim U., Tracier-Eugster H., Jakob M. Studies on the immune status of children with acute lymphoblastic leukemia. Clin. Exp. Immunol. 1976; 26: 403–413
   PubMed Web of Science ®Google Scholar
• Orgel H. A., Hamburger R. N., Mendelson L. M., Miller J. R., Kunc F. H. Antibody response in normal infants and in infants receiving chemotherapy for congenital neuroblastoma. Cancer 1977; 40: 994–997, See also Ridgway, Wolff, and Deforest (reference 10) and van der Does-van den Berg et al. (reference 77)
   PubMed Web of Science ®Google Scholar
• Feldman S., Hughes W. T., Daniel C. B. Varicella in children with cancer: seventy-seven cases. Pediatr. 1975; 56: 388–397
   PubMed Web of Science ®Google Scholar
• Feldman S., Lott L. Varicella in children with cancer: impact of antiviral therapy and prophyllaxis. Pediatr. 1987; 80: 465–472
   PubMed Web of Science ®Google Scholar
• Pinkie D. Chicken pox and leukemia. J. Pediatr. 1961; 58: 729–737
   PubMed Web of Science ®Google Scholar
• Good R. A., Vernier R. L., Smith R. T. Serious untoward reactions to therapy with cortisone and adrenocorti-cotropin in pediatric practice. Pediatr. 1957; 19: 89–118
   Google Scholar
• Haggerty R. F., Eley R. C. Varicella and cortisone. Pediatr. 1956; 18: 160–162
   PubMed Web of Science ®Google Scholar
• Cheatham W. J., Weller T. H., Dolan T. F., Dower J. C. Varicella: report of two fatal cases with necropsy, virus isolation, and serologic studies. Am. J. Pathol. 1956; 32: 1015–1035
   PubMed Web of Science ®Google Scholar
• Dolin R., Reichman R. C., Mazur M. H., Whitley R. J. Herpes zoster-varicella infections in immunosup-pressed patients. Ann. Intern. Med. 1978; 89: 375–388
   PubMed Web of Science ®Google Scholar
• Bodey G., McKelvey E., Karon M. Chicken pox in leukemic patients: factors in prognosis. Pediatr. 1964; 34: 562–564
   PubMed Web of Science ®Google Scholar
• Preblud S. R., Orenstein W. A., Bart K. J. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr. Infect. Dis. 1984; 3: 505–509
   PubMedGoogle Scholar
• Zaia J. A., Levin M. J., Preblud S. R., Leszczynski J., Wright G. G., Ellis R. J., Curtis A. C., Valerio M. A., LeGore J. Evaluation of varicella-zoster immune globulin. Protection of immunosuppressed children after household exposure to varicella. J. Infect. Dis. 1983; 147: 737–743
   PubMed Web of Science ®Google Scholar
• Gruson S., Mouchnino G., Reinert P., Patte C. Varicelles et zonas chez 83 enfants traites pour une affection maligne. Arch. Fr. Pediatr. 1981; 38: 337–343
   PubMedGoogle Scholar
• Ritter J., Voigt D., Hoese G., Schellonc G. Special aspects of supportive therapy in childhood acute leukemias. Haematolog. Blood Transfus. 1987; 30: 182–187
   PubMedGoogle Scholar
• Dunkle L. M., Arvin A. M., Whitley R. J., Rot Bart H. A., Feder H. M., Feldman S., Gershon A. A., Levy M. L., Hayden G. F., McGuirt P. V., Harris J., Balfour H. H. A controlled trial of acyclovir for chickenpox in normal children. N. Engl. J. Med. 1991; 325: 1539–1544
   PubMed Web of Science ®Google Scholar
• Stevens D. A., Ferrington R. A., Jordan G. W., Merigan T. C. Cellular events in zoster vesicles: relation to clinical course and immune parameters. J. Infect. Dis. 1975; 131: 509–515
   PubMed Web of Science ®Google Scholar
• Patel P. A., Yoonessi S., O'Malley J., Freeman A., Gershon A., Orga P. L. Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia. J. Pediatr. 1979; 94: 223–230
   PubMed Web of Science ®Google Scholar
• Taylor-Weideman J., Brunel L. P. A., Geiser C., Shelab Z. M., Frierson L. S. Effect of transfusions on serologic testing for antibody to varicella. Med. Pediatr. Oncolog. 1986; 14: 316–318
   PubMedGoogle Scholar
• Baba K., Yabuuchi H., Okuni H., Takahashi M. Studies with live varicella vaccine and inactivated skin test antigen: protective effect of the vaccine and clinical application of the skin test. Pediatr. 1978; 61: 550–555
   PubMed Web of Science ®Google Scholar
• Kamiya H., Ihara T., Hattori A., Iwasa T., Sakurai M., Izawa T., Yamada A., Takahashi M. Diagnostic skin reaction with varicella antigen and its clinical application at occurrence of varicella patients in an institution for handicapped children. J. Infect. Dis. 1977; 136: 784–788
   PubMed Web of Science ®Google Scholar
• Weibel R. E., Neff B. J., Kuter B. J., Guess H. A., Rothenberger C. A., Fitzgerald A. J., Connor K. A., McLean A. A., Hilleman M. R., Buynak E. B., Scolnick E. M. Live attenuated varicella vaccine. N. Engl. J. Med. 1984; 310: 1409–1415
   PubMed Web of Science ®Google Scholar
• Starr S. E. Status of varicella vaccine for healthy children. Pediatr. 1989; 84: 1097–1099
   PubMed Web of Science ®Google Scholar
• Brunnell P. A. Commentary: protection against varicella. Pediatr. 1977; 59: 1–2
   PubMed Web of Science ®Google Scholar
• Marwick C. Varicella vaccine licensing in 18 to 24 months?. JAMA 1987; 258: 3215–3216
   PubMed Web of Science ®Google Scholar
• Johnson C., Rome L. P., Stancin T., Kumar M. L. Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pedialr. 1989; 84: 418–421
   Google Scholar
• Takahashi M., Okuno Y., Otsuka T., Osame J., Takamiza-wa A., Sasada T., Kubo T. Development of live attenuated varicella vaccine. Biken., J. 1975; 18: 24–33
   Google Scholar
• Diaz P. S., Au D., Smith S., Amylon M., Link M., Smith S., Arvin A. M. Lack of transmission of live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Pediatr. 1991; 87: 166–170
   PubMed Web of Science ®Google Scholar
• Arbeter A. M., Granowetter L., Starr S. E., Lange B., Wimmer R., Plotkin S. A. Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without suspension of chemotherapy. Pediatr. 1990; 85: 338–344
   PubMed Web of Science ®Google Scholar
• Oka T., Iseki K., Oka R., Sakuma S., Yosjika H., Takahashi M. Evaluation of varicella vaccine in childhood leukemia: observation over 6 years. Biken J 1984; 27: 103–109
   PubMedGoogle Scholar
• Ha K., Baba K., Ikeda T., Nishida M., Yabuuchi H., Takahashi M. Application of live varicella vaccine to children with leukemia or other malignancies without suspension of anticancer therapy. Pediatr. 1980; 65: 346–350
   PubMed Web of Science ®Google Scholar
• Andre F. E. Summary of clinical studies with the Oka live varicella vaccine produced by Smith Kline-Rit. Biken. J. 1984; 27: 89–98
   PubMedGoogle Scholar
• Tsolia M., Gershon A. A., Steinberg S. P., Gelb L. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. J. Pediatr. 1990; 116: 184–189
   PubMed Web of Science ®Google Scholar
• Lawrence R., Gershon A. A., Holzman R., Steinberg S. P., NIAID Varicella Vaccine Collaborative Study Group. The risk of zoster in leukemic children who received live attenuated varicella vaccine. N. Engl. J. Med. 1988; 318: 543–548
   PubMed Web of Science ®Google Scholar
• Hardy I., Gershon A. A., Steinberg S. P., LaRussa P., Varicella Vaccine Collaborative Study Group. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N. Engl. J. Med. 1991; 325: 1545–1550
   PubMed Web of Science ®Google Scholar
• Ihara T., Kimiya H., Tongue S., Sakurai M., Takahashi M. Viremic phase in a leukemic child after live varicella vaccination. Pediatr. 1992; 89: 147–149
   PubMed Web of Science ®Google Scholar
• Takahashi M. Clinical overview of varicella vaccine: development and early studies. Pedialr. 1986; 78: 736–741
   Google Scholar
• Gershon A. A., Steinberg S. P., Gelb L. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatr. 1986; 78: 757–762
   PubMed Web of Science ®Google Scholar
• Bruneil P. A., Shehab Z., Geiser C., Waugh J. E. Administration of live varicella vaccine to children with leukemia. Lancet. 1982; ii: 1069–1072
   Google Scholar
• Gershon A. A., Steinberg S. P., Gelb L., Galasso G., Borkowsky W., LaRussa P., Ferrara A. Live attenuated varicella vaccine. Efficacy for children with leukemia in remission. JAMA 1984; 252: 355–362
   PubMed Web of Science ®Google Scholar
• Izawa T., Ihara T., Hattori A., Iwasa T., Kamiya H., Sakurai M., Takahashi M. Application of a live varicella vaccine in children with acute leukemia or other malignant disease. Pediatr. 1977; 60: 805–809
   PubMed Web of Science ®Google Scholar
• Ozaki T., Nagayoshi I. S., Morishima T., Isomura S., Suzuki S., Asano Y., Takahashi M. Use of a live varicella vaccine for acute leukemia children shortly after exposure in a children's ward. Biken, J. 1978; 21: 69–72
   PubMedGoogle Scholar
• Gershon A. A. Live attenuated varicella vaccine. Annu. Rev. Med. 1987; 38: 41–50
   PubMed Web of Science ®Google Scholar
• Brunell P. A., Taylor-Wiedeman J., Geiser C. F., Frierson L., Lydick E. Risk of herpes zoster in children with leukemia: Varicella vaccine compared with history of chicken pox. Pediatr. 1986; 77: 53–56
   PubMed Web of Science ®Google Scholar
• Gershon A. A., Steinberg S. P. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N. Engl. J. Med. 1989; 320: 892–897
   PubMed Web of Science ®Google Scholar
• Takahashi M., Otsuka T., Okuna Y., Asano Y., Yazaki T., Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974; ii: 1288–1290
   Google Scholar